Trials / Unknown
UnknownNCT03914222
Comparing PA Compliance During and After Decompensation in HFP
Comparison of Noninvasive Pulmonary Artery Compliance During and After Decompensation in Heart Failure Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Theranova, L.L.C. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary Artery Compliance measurements will be obtained with the Respirix device in patients with congestive heart failure decompensation. Echocardiogram, weight measurements, and BNP will also be gathered as independent measures of decompensation in the clinic. Pulmonary Artery Compliance measurements will be made daily during the hospital stay. Patients can continue using the device at home for the next 3 weeks. Each patient will serve as their own control and relative changes from their baseline will be recorded for each parameter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardioSpire (Respirix) Device | Patients will blow into the device through a small tube, which analyzes the signals in the airway patterns. |
Timeline
- Start date
- 2019-06-24
- Primary completion
- 2019-12-01
- Completion
- 2020-02-01
- First posted
- 2019-04-16
- Last updated
- 2019-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03914222. Inclusion in this directory is not an endorsement.